DK0478602T3 - Ekspression af tetanus toxin fragment C - Google Patents

Ekspression af tetanus toxin fragment C

Info

Publication number
DK0478602T3
DK0478602T3 DK90909052.4T DK90909052T DK0478602T3 DK 0478602 T3 DK0478602 T3 DK 0478602T3 DK 90909052 T DK90909052 T DK 90909052T DK 0478602 T3 DK0478602 T3 DK 0478602T3
Authority
DK
Denmark
Prior art keywords
tetanus toxin
expression
toxin fragment
fragment
mature fragment
Prior art date
Application number
DK90909052.4T
Other languages
English (en)
Inventor
Neil Fraser Fairweather
Andrew Joseph Makoff
Original Assignee
Evans Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evans Medical Ltd filed Critical Evans Medical Ltd
Application granted granted Critical
Publication of DK0478602T3 publication Critical patent/DK0478602T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK90909052.4T 1989-06-20 1990-06-20 Ekspression af tetanus toxin fragment C DK0478602T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898914122A GB8914122D0 (en) 1989-06-20 1989-06-20 Polypeptide expression

Publications (1)

Publication Number Publication Date
DK0478602T3 true DK0478602T3 (da) 1996-02-05

Family

ID=10658724

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90909052.4T DK0478602T3 (da) 1989-06-20 1990-06-20 Ekspression af tetanus toxin fragment C

Country Status (9)

Country Link
US (1) US5443966A (da)
EP (1) EP0478602B1 (da)
JP (1) JP2981286B2 (da)
AT (1) ATE132532T1 (da)
DE (1) DE69024652T2 (da)
DK (1) DK0478602T3 (da)
ES (1) ES2084030T3 (da)
GB (1) GB8914122D0 (da)
WO (1) WO1990015871A1 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5601826A (en) * 1989-06-30 1997-02-11 The United States Of America As Represented By The Department Of Health And Human Services Peptide which produces protective immunity against tetanus
GB9209118D0 (en) * 1992-04-28 1992-06-10 Sb 120 Amsterdam Bv Vaccine compositions
WO1994000487A1 (en) * 1992-06-30 1994-01-06 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Peptide which produces protective immunity against tetanus
ES2127829T3 (es) 1992-07-31 1999-05-01 Medeva Holdings Bv Expresion de proteinas recombinantes fusionadas en bacterias atenuadas.
GB9401787D0 (en) * 1994-01-31 1994-03-23 Medeva Holdings Bv Vaccine compositions
US20030185792A1 (en) * 1996-01-22 2003-10-02 Curis, Inc. Morphogen analogs of bone morphogenic proteins
AU725295B2 (en) * 1996-01-22 2000-10-12 Brandeis University Morphogen analogs and methods for producing them
DE69731357T2 (de) * 1996-03-23 2006-02-02 The Research Foundation For Microbial Diseases Of Osaka University, Suita Funktionelles antigenfragment von tetanustoxin und tetanusvakzine
US5958469A (en) * 1997-05-14 1999-09-28 Eastman Kodak Company Method for fabricating tools for molding diffractive surfaces on optical lenses
US20100081197A1 (en) * 1997-08-14 2010-04-01 Sylvie Roux In vivo modulation of neuronal transport
US7923216B2 (en) 1997-08-14 2011-04-12 Institut Pasteur In vivo modulation of neuronal transport
ES2281135T3 (es) * 1997-08-14 2007-09-16 Institut Pasteur Proteinas hibridas de un toxoide tetanico que migran de forma retrograda y transinaptica al snc.
GB0108364D0 (en) 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
PT1296715E (pt) 2000-06-29 2012-01-19 Smithkline Beecham Biolog Composição vacinal multivalente
EP1575505A4 (en) * 2002-09-10 2007-01-24 Vical Inc CODON OPTIMIZATION-BASED POLYNUCLEOTIDE VACCINES AGAINST BACILLUS ANTHRACIS INFECTION
DE602004017864D1 (de) * 2003-06-23 2009-01-02 Baxter Int Trägerproteine für impfstoffe
US20070092449A1 (en) * 2005-04-05 2007-04-26 Rafael Vazquez-Martinez Methods for direct visualization of active synapses
EP1790358A1 (en) * 2005-11-23 2007-05-30 Université de Reims Champagne-Ardennes Protein constructs designed for targeting and lysis of cells
AU2007293673B2 (en) 2006-09-07 2013-06-27 Glaxosmithkline Biologicals S.A. Vaccine
EP2142211A1 (en) 2007-05-02 2010-01-13 GlaxoSmithKline Biologicals S.A. Vaccine
NZ602958A (en) 2010-03-30 2014-07-25 Pfenex Inc High level expression of recombinant toxin proteins
WO2011143557A2 (en) 2010-05-14 2011-11-17 The Children's Hospital Of Philadelphia Humanized ttc and methods of use thereof
GB201105981D0 (en) 2011-04-08 2011-05-18 Glaxosmithkline Biolog Sa Novel process
WO2013083254A1 (en) 2011-12-09 2013-06-13 Bavarian Nordic A/S Poxvirus vector for the expression of bacterial antigens linked to tetanus toxin fragment c
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
DK2863943T3 (da) 2013-03-08 2016-11-07 Janssen Vaccines & Prevention Bv Acellulær pertussisvaccine
JP2017521408A (ja) 2014-07-02 2017-08-03 スフェリウム バイオメッド エス．エル． 無毒性破傷風毒素ｃフラグメント（ｔｔｃ）を使用して筋量を増加させる方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2355094C3 (de) * 1973-11-03 1979-05-23 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines Tetanus-Impfstoffs
GB8516442D0 (en) * 1985-06-28 1985-07-31 Wellcome Found Cloned antigen

Also Published As

Publication number Publication date
JP2981286B2 (ja) 1999-11-22
EP0478602A1 (en) 1992-04-08
DE69024652T2 (de) 1996-05-15
US5443966A (en) 1995-08-22
WO1990015871A1 (en) 1990-12-27
EP0478602B1 (en) 1996-01-03
GB8914122D0 (en) 1989-08-09
JPH04506005A (ja) 1992-10-22
ES2084030T3 (es) 1996-05-01
DE69024652D1 (de) 1996-02-15
ATE132532T1 (de) 1996-01-15

Similar Documents

Publication Publication Date Title
DK0478602T3 (da) Ekspression af tetanus toxin fragment C
DK0652758T3 (da) Diferitoxin-vacciner
ES2103366T3 (es) Hidrolizado proteico de guisante, metodo para su produccion y su utilizacion.
DE69002817D1 (de) Vakzine.
DK0423302T3 (da) Anvendelse af hidtil ukendte DNA-fragmenter som kodende sekvens for et signalpeptid til sekretion af modne proteiner i rekombinant gær, ekspressionskassetter, transformeret gær og tilsvarende fremgangsmåde til fremstilling af proteiner
DK0663010T3 (da) Fremgangsmåde til forøgelse af sekretion af overudtrykte proteiner
BR9007883A (pt) Producao de inibidor de interleucina-1 humana recombinante
DE59308000D1 (de) Immunoassay zum nachweis von kollagen oder kollagenfragmenten
SE9201544L (sv) Saett att framstaella glykosyltransferaser
MY107819A (en) Preparation of substituted piperidines.
IT1211116B (it) Procedimento per lapreparazione di 4'-deossi-daunorubicina 4'-deossi-doxorubicina.
JPS5732077B2 (da)
IT1250692B (it) Procedimento per la preparazione di demetilepipodofillotossina- beta-d-glucosidi.
ATE81136T1 (de) Immunogenes produkt, erhalten durch expression in einer rekombinanten hefe, und verfahren zu seiner reinigung.
NZ239249A (en) Pure gelonin toxin and its corresponding dna sequence
NO913078L (no) Oekt proteinproduksjon i dyr.
ES2023560A6 (es) Procedimiento para la produccion de hidrato de cefradina y solvato de cefradina y dimetilformamida.
ATE194624T1 (de) Mutanten von menschlichem antithrombin iii
SE8403929D0 (sv) Recombinant dna molecule, transformed microorganisms and process for producing penicillin v amidase
DK0536564T3 (da) Fremgangsmåde til fremstilling af streptolysin O, intakt streptolysin O fremstillet ved denne fremgangsmåde og dets anvendelse
DK0456986T3 (da) Varmeresistent beta-galactosyltransferase, fremtillingsfremgangsmåde herfor og anvendelse heraf
ATE126794T1 (de) Verfahren zur herstellung von formyltetrahydropyranen.
DE69024159D1 (de) 3-Aroyl-2-Oxindol-1-Carboxamide
NO843750L (no) Immuninterferon og fremgangsmaate ved fremstilling derav
JPS53141262A (en) Coriolin derivative and process for their preparation